Monografie
Augmenting bispecific T-cell engager (BiTE) therapy for the treatment of Acute Myeloid Leukemia
- Sprache
-
Englisch
- Identifier
-
1255225165
Thema
Therapeutics
Beteiligte Personen und Organisationen
Brauchle, Bettina
Subklewe, Marion
Subklewe, Marion
- DOI
-
10.5282/edoc.29384
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
03.06.2022, 09:17 MESZ
Objekttyp
- Monografie
Beteiligte
- Brauchle, Bettina
- Subklewe, Marion
Ähnliche Objekte (12)
Nanotools for cancer research and therapy
Hypoplastic left heart syndrome: surgical therapy
Low-dose imaging for particle therapy with fluence-modulated proton computed tomography
Assessing novel modalities for the therapy of inflammatory bowel disease
A patient-specific CT-Mesh hybrid computational phantom and its applications in out-of-field dose, equivalent dose, and secondary cancer risk estimation in proton therapy
The role of the TGFβ signaling pathway in clinically non-functioning pituitary adenoma and the potential role of inhibitors of this pathway as a new target in pituitary tumor therapy
Synthesis of modified oligonucleotides for prebiotic studies and as novel CoV-2 therapeutics
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
Enhancing dendritic cell vaccination by immune checkpoint blockade as therapy in AML
Myeloid cells and therapy resistance in Chronic Lymphocytic Leukemia
CXCR4-directed Imaging and Therapy in Acute Leukemia
Studies on chemokine and cytokine release in Akute Myeloid Leukemia and Myelodysplastic Syndromes
Nanotools for cancer research and therapy
Hypoplastic left heart syndrome: surgical therapy
Low-dose imaging for particle therapy with fluence-modulated proton computed tomography
Assessing novel modalities for the therapy of inflammatory bowel disease
A patient-specific CT-Mesh hybrid computational phantom and its applications in out-of-field dose, equivalent dose, and secondary cancer risk estimation in proton therapy
The role of the TGFβ signaling pathway in clinically non-functioning pituitary adenoma and the potential role of inhibitors of this pathway as a new target in pituitary tumor therapy
Synthesis of modified oligonucleotides for prebiotic studies and as novel CoV-2 therapeutics
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
Enhancing dendritic cell vaccination by immune checkpoint blockade as therapy in AML
Myeloid cells and therapy resistance in Chronic Lymphocytic Leukemia
CXCR4-directed Imaging and Therapy in Acute Leukemia
Studies on chemokine and cytokine release in Akute Myeloid Leukemia and Myelodysplastic Syndromes
Nanotools for cancer research and therapy
Hypoplastic left heart syndrome: surgical therapy
Low-dose imaging for particle therapy with fluence-modulated proton computed tomography
Assessing novel modalities for the therapy of inflammatory bowel disease
A patient-specific CT-Mesh hybrid computational phantom and its applications in out-of-field dose, equivalent dose, and secondary cancer risk estimation in proton therapy
The role of the TGFβ signaling pathway in clinically non-functioning pituitary adenoma and the potential role of inhibitors of this pathway as a new target in pituitary tumor therapy
Synthesis of modified oligonucleotides for prebiotic studies and as novel CoV-2 therapeutics
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
Enhancing dendritic cell vaccination by immune checkpoint blockade as therapy in AML
Myeloid cells and therapy resistance in Chronic Lymphocytic Leukemia
CXCR4-directed Imaging and Therapy in Acute Leukemia